Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 10, 2017
[ Tue, Oct 10th 2017
] - WOPRAI
[ Tue, Oct 10th 2017
] - WOPRAI
[ Tue, Oct 10th 2017
] - WOPRAI
Mon, October 9, 2017
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
Fri, October 6, 2017
[ Fri, Oct 06th 2017
] - WOPRAI
[ Fri, Oct 06th 2017
] - WOPRAI
Michael Weinstein Initiated (ABT) at Hold and Held Target at $60 on, Oct 6th, 2017
Michael Weinstein of JP Morgan, Initiated "Abbott Laboratories" (ABT) at Hold and Held Target at $60 on, Oct 6th, 2017.
Michael has made no other calls on ABT in the last 4 months.
There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Amit Hazan of "Citigroup" Initiated at Hold and Held Target at $53 on, Thursday, August 17th, 2017
- David Lewis of "Morgan Stanley" Maintained at Hold with Increased Target to $49 on, Monday, July 10th, 2017
These are the ratings of the 4 analyists that currently disagree with Michael
- Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $60 on, Thursday, September 28th, 2017
- Brittany Henderson of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $56 on, Friday, July 21st, 2017
- David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $62 on, Friday, July 21st, 2017
- Christopher Pasquale of "Guggenheim" Initiated at Strong Buy and Held Target at $58 on, Thursday, June 29th, 2017
